AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Why Did Indaptus Therapeutics Plunge 28.89%?
Generated by AI AgentAinvest Pre-Market Radar
Wednesday, Jun 25, 2025 7:34 am ET1min read
On June 25, 2025,
experienced a significant drop of 28.89% in pre-market trading, marking a notable decline in its stock performance.Indaptus Therapeutics has announced a reverse stock split, effective from June 27, 2025. This move aims to increase the company's per-share price to meet Nasdaq's continued listing requirements and potentially attract more investors. The common stock will trade on the Nasdaq Capital Market under a new CUSIP number, 45339J 204, following the split.
Indaptus Therapeutics has also completed a private placement of convertible notes and warrants, raising $2.3 million. This financial maneuver is part of the company's strategy to bolster its liquidity and support ongoing operations and development efforts.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Galiano Gold (TSE:GAU) Surged 5.35% on Improving Gold Sector Fundamentals and Valuation Dynamics
Dec.22 2025
Metallus shares plunged 6.73% amid escalating labor tensions as workers rejected second proposed contract.
Dec.22 2025
enCore Energy shares surge 14.04% on renewed confidence after weeks of volatility
Dec.22 2025
Broadcom Inc. (NASDAQ:AVGO) Surges 3.18% on Upgraded Price Targets and Bullish Analyst Commentary
Dec.22 2025
Oracle shares surged 6.63% driven by renewed investor optimism from key strategic developments
Dec.22 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet